MOUSE HEMATOPOIETIC STEM-CELLS AND THE INTERACTION OF C-KIT RECEPTOR AND STEEL FACTOR

被引:0
|
作者
IKUTA, K
INGOLIA, DE
FRIEDMAN, J
HEIMFELD, S
WEISSMAN, IL
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305
[2] STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,STANFORD,CA 94305
[3] CELLPRO,BOTHELL,WA
来源
关键词
HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; C-KIT; STEEL FACTOR; ANEMIA; PROGENITOR; GROWTH FACTOR;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hematopoietic stem cells (HSCs) are distinguished from other hematopoietic progenitors in bone marrow by their unique ability to undergo multilineage differentiation and self-renewal. Two mouse mutations, dominant spotting (W) and steel (Sl), have pleiotropic effects on hematopoiesis, gametogenesis, and melanoblast development. These two mutations have been shown to be intrinsic (W) and microenvironmental (Sl) defects. Recently, molecular studies revealed that the W and Sl loci encode the c-kit receptor and steel factor (SLF), respectively. The c-kit receptor is expressed on HSCs and hematopoietic progenitors, while SLF is produced by stromal cells. SLF acts on hematopoietic progenitors synergistically with other growth factors. Here we review the effect of these mutations on mouse hematopoiesis, and show that SLF acts on HSCs and other myeloerythroid progenitors, but that it, in our hands, does not play a critical role in HSC generation or self-renewal. Rather, SLF is the most potent co-mitogen (with IL-1, IL-3, IL-6, G-CSF, GM-CSF, or M-CSF) found that acts on these cells, but the effect of such treatments is the rather specific and massive expansion of myeloerythropoiesis, not lymphopoiesis, and perhaps at the expense of HSC self-renewal.
引用
收藏
页码:451 / 460
页数:10
相关论文
共 50 条
  • [21] A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase
    Zhi-Chao Feng
    Matthew Riopel
    Alex Popell
    Rennian Wang
    Diabetologia, 2015, 58 : 654 - 665
  • [22] A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase
    Feng, Zhi-Chao
    Riopel, Matthew
    Popell, Alex
    Wang, Rennian
    DIABETOLOGIA, 2015, 58 (04) : 654 - 665
  • [23] INTERACTION OF HUMAN-LYMPHOCYTES WITH MOUSE HEMATOPOIETIC STEM-CELLS
    PETROV, RV
    DOZMOROV, IM
    ZADOROZHNYI, SI
    ORLOV, EV
    DOKLADY AKADEMII NAUK SSSR, 1987, 296 (01): : 246 - 248
  • [24] The potential role of stem cell factor and its receptor c-kit in the mouse blastocyst implantation
    Mitsunari, M
    Harada, T
    Tanikawa, M
    Iwabe, T
    Taniguchi, F
    Terakawa, N
    MOLECULAR HUMAN REPRODUCTION, 1999, 5 (09) : 874 - 879
  • [25] The role of truncated c-kit receptor (tr-kit) in maintenance and differentiation of hematopoietic stem cells and multipotent hematopoietic progenitors.
    Yang, J
    Saltiel, CI
    Nachtman, RG
    Jing, X
    Jurecic, R
    BLOOD, 2005, 106 (11) : 129B - 129B
  • [26] CHARACTERIZATION OF C-KIT POSITIVE INTRATHYMIC STEM-CELLS THAT ARE RESTRICTED TO LYMPHOID DIFFERENTIATION
    MATSUZAKI, Y
    GYOTOKU, J
    OGAWA, M
    NISHIKAWA, S
    KATSURA, Y
    GACHELIN, G
    NAKAUCHI, H
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 21 - 21
  • [27] CHARACTERIZATION OF C-KIT POSITIVE INTRATHYMIC STEM-CELLS THAT ARE RESTRICTED TO LYMPHOID DIFFERENTIATION
    MATSUZAKI, Y
    GYOTOKU, J
    OGAWA, M
    NISHIKAWA, S
    KATSURA, Y
    GACHELIN, G
    NAKAUCHI, H
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04): : 1283 - 1292
  • [28] Murine hematopoietic stem cells and multipotent progenitors express truncated intracellular form of c-kit receptor
    Zayas, Jennifer
    Spassov, Danislav S.
    Nachtman, Ronald G.
    Jurecic, Roland
    STEM CELLS AND DEVELOPMENT, 2008, 17 (02) : 343 - 353
  • [29] Induction of c-kit molecules on human CD34+/c-kit(<low) cells: Evidence for CD34+/c-kit(<low) cells as primitive hematopoietic stem cells
    Sogo, S
    Inaba, M
    Ogata, H
    Hisha, H
    Adachi, Y
    Mori, S
    Toki, J
    Yamanishi, K
    Kanzaki, H
    Adachi, M
    Ikehara, S
    STEM CELLS, 1997, 15 (06) : 420 - 429
  • [30] The stem cell factor receptor/c-Kit as a drug target in cancer
    Lennartsson, J
    Rönnstrand, L
    CURRENT CANCER DRUG TARGETS, 2006, 6 (01) : 65 - 75